Stephen G. Sudovar
Directeur Général chez SGS Associates
Profil
Stephen G.
Sudovar is currently the President & Chief Executive Officer at SGS Associates, Vice Chairman at Kessler Foundation Inc, and a Professor at Montclair State University.
Previously, he served as the President & Chief Executive Officer at Elusys Therapeutics, Inc. from 1999 to 2005, Chairman & Chief Executive Officer at Ambrilia Biopharma, Inc. from 2006 to 2007, and Chairman & Chief Executive Officer at Pracon, Inc. He also held the position of Director at Nabi Biopharmaceuticals from 2002 to 2010 and at Vericel Corp.
from 2005 to 2009.
Additionally, he was a Director at AtheroGenics, Inc. and served as the President of Roche Laboratories, Inc. from 1988 to 1999.
Mr. Sudovar holds an MBA from Fairleigh Dickinson University and an undergraduate degree from Saint Peter's University.
Postes actifs de Stephen G. Sudovar
| Sociétés | Poste | Début |
|---|---|---|
| SGS Associates | Directeur Général | - |
| Montclair State University | Corporate Officer/Principal | - |
Kessler Foundation Inc
 Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | Directeur/Membre du Conseil | - |
Anciens postes connus de Stephen G. Sudovar
| Sociétés | Poste | Fin |
|---|---|---|
Nabi Biopharmaceuticals
 Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Directeur/Membre du Conseil | 20/05/2010 |
| VERICEL CORPORATION | Directeur/Membre du Conseil | 03/10/2009 |
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Président | 13/06/2007 |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | President | 01/01/2005 |
Roche Laboratories, Inc.
 Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ. | President | 01/08/1999 |
Formation de Stephen G. Sudovar
| Fairleigh Dickinson University | Masters Business Admin |
| Saint Peter's University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VERICEL CORPORATION | Health Technology |
| Entreprise privées | 8 |
|---|---|
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Health Technology |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Health Technology |
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Health Technology |
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Health Technology |
| SGS Associates | |
Roche Laboratories, Inc.
Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ. | Distribution Services |
| Pracon, Inc. | |
Kessler Foundation Inc
Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | Commercial Services |